Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome - Relation to arterial hypotension and tumor necrosis factor

Infection

Volumn 24, Issue 5, 1996, Pages 337-340

  Linderholm, M ^a   Groeneveld, P H P ^b   Tarnvik A ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; NITRATE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTENSION; MALE; VIRUS HEMORRHAGIC FEVER;

ADULT; AGED; FEMALE; HANTAVIRUS INFECTIONS; HUMANS; HYPOTENSION; KIDNEY FAILURE; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; PLASMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029857572     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01716075     Document Type: Article

References (17)

1. Cosgriff, T. M.: Mechanisms of disease in hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev. Infect. Dis. 13 (1991) 97-107.
2. Duchin, J. S., Koster, F. T., Peters, C. J., Simpson, G. L., Tempest, B., Zaki, S. R., Ksiazek, D. V. M., Rollin, P. E., Nichol, S., Umland, E. T., Moolenaar, R. L., Reef, S. E., Nolte, K. B., Gallaher, M. M., Butler, J. C., Breiman, R. F., and the Hantavirus Study Group: Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N. Engl. J. Med. 330 (1994) 949-955.
3. Settergren, B., Juto, P., Trollfors, B., Wadell, G., Norrby, S. R.: Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Rev. Infect. Dis. 11 (1989) 921-927.
4. Linderholm, M., Ahlm, C., Settergren, B., Waage, A., Tärnvik, A.: Elevated plasma levels of tumor necrosis factor (TNF)-α, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173 (1996) 38-43.
5. Spriggs, D. R., Sherman, M. L., Michie, H., Arthur, K. A., Imamura, K., Wilmore, D., Frei III, E., Kufe, D. W.: Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacological study. J. Natl. Cancer Inst. 80 (1988) 1039-1044.
6. Moncada, S.: The L-arginine: nitric oxide pathway. Acta Physiol. Scand. 145 (1992) 201-227.
7. Hibbs, J. B. Jr., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baranowski, R. L., Ward, J. H., Menlove, R. L., McMurry, M. P., Kushner, J. P., Samlowski, W. E.: Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89 (1992) 867-877.
8. Groeneveld, P. H. P., Colson, P., Kwappenberg, K. M. C., Clement, J.: Increased production of nitric oxide in patients infected with the European variant of hantavirus. Scand. J. Infect. Dis. 27 (1995) 453-456.
9. Elgh, F., Wadell, G., Juto, P.: Comparison of the kinetics of Puumala virus specific IgM and IgG antibody responses in nephropathia epidemica as measured by a recombinant antigen-based enzyme-linked immunosorbent assay and an immunofluorescent test. J. Med. Virol. 45 (1995) 146-150.
10. 15N-labeled nitrate in humans: effect of diet supplementation with ascorbic acid. Canc. Res. 43 (1983) 1921-1925.
11. Deakin, A. M., Payne, A. N., Whittle, B. J. R., Moncada, S.: The modulation of IL-6 and TNF-α release by nitric oxide following stimulation of J774 cells with LPS and IFN-γ. Cytokine 7 (1995) 408-416.
12. Evans, T., Carpenter, A., Kinderman, H., Cohen, J.: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ. Shock 41 (1993) 77-81.
13. Ochoa, J. B., Udekwu, A. O., Billiar, T. R., Curran, R. D., Cerra, F. B., Simmons, R. L., Peitzman, A. B.: Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214 (1991) 621-626.
14. Reyes, A. A., Martin, D., Settle, S., Klahr, S.: EDRF role in renal function and blood pressure of normal rats and rats with obstructive nephropathy. Kidney Int. 41 (1992) 403-413.
15. Narita, I., Border, W. A., Ketteler, M., Noble, N. A.: Nitric oxide mediates immunological injury to kidney mesangium in experimental glomerulonephritis. Lab. Invest. 72 (1995) 17-24.
16. Radomski, M. W., Palmer, R. M. J., Moncada, S.: The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 148 (1987) 1482-1489.
17. Evans, T., Carpenter, A., Silva, A., Cohen, J.: Inhibition of nitric oxide synthase in experimental gram-negative sepsis. J. Infect. Dis. 169 (1994) 343-349.